Henry Fisher (@_Hydrofluoric) header
Henry Fisher (@_Hydrofluoric) profile picture

Chief Scientific Officer of Clerkenwell Health @clerkenwell_uk, psychedelic specialist CRO, co-founder and CSO @hanway_assocs cannabis strategic consultancy

London, England
Joined November 2010
Photo by Henry Fisher (@_Hydrofluoric)Photo by Henry Fisher (@_Hydrofluoric)Photo by Henry Fisher (@_Hydrofluoric)Photo by Henry Fisher (@_Hydrofluoric)Photo by Henry Fisher (@_Hydrofluoric)Photo by Henry Fisher (@_Hydrofluoric)Photo by Henry Fisher (@_Hydrofluoric)Photo by Henry Fisher (@_Hydrofluoric)Photo by Henry Fisher (@_Hydrofluoric)Photo by Henry Fisher (@_Hydrofluoric)
Henry Fisher retweeted
We are running a survey on post-psychedelic trip difficulties and what helped to cope with which specific difficulty, so if you have had extended challenging psychedelic experiences please do this 15min survey... all respondents get a copy of Jules' book Breaking Open
This Post is from an account that no longer exists. Learn more
5
9
1,119
Henry Fisher retweeted
No. That’s not how this works. Any serious company seeking fda approval is going to look at how MAPS conducted itself, and then do better, or suffer the same fate
Replying to @Drug_Science
4/7 "...If the FDA follows the panel's recommendations, it will be very deleterious for the field. "Concerns about unblinding are overblown and would apply equally to other drugs such as antipsychotics. So why focus on it here?"
1
2
14
1,818
Henry Fisher retweeted
This is one of the 2 big lessons for me: listen and even amplify criticism - medical scientists can never forget that it is all about the patients and the patients are often vulnerable. Engaging with criticism is the only honest and ethical way to do psychiatric science.
This Post is from an account that no longer exists. Learn more
2
1
3
327
Henry Fisher retweeted
Really delighted to have joined the teaching faculty of Clerkenwell Health for their "Psychedelic Practitioner Foundation Programme". Follow this link to find out more (via the FAQ) and to sign up for the Foundation Programme. training.clerkenwellhealth.c…
1
5
16
848
Such sad news - harm reduction pioneer and source of huge amounts of knowledge. RIP Dr Nuke
Desperately sad news that Russell Newcombe has died. Educator, campaigner, harm reduction trailblazer, psychonaut, and an endlessly fascinating, generous and lovely human - He will be terribly missed. RIP 😔 1/
4
614
With @neurodelia and @Imperial_PRG we just launched a 🆒🆕 study to understand the practices used in underground #psychedelic therapy and how they differ from what we do in clinical trials. Please RT, forward to relevant ppl in your network🙏 More info: tinyurl.com/yey7ptmm
1
18
1
34
4,132
Please RT: We’re running a study looking at people’s experience of ketamine addiction treatment - heavy ketamine users current and past welcome bit.ly/ket-survey
15
2
13
3,307
One of those amazing people full of the most incredible stories that seems to always have been at the right place at the right time in history. He'll be missed by many!
Sad to hear of the passing of Lee Harris. A kind soul who lived a life unlike any other. An anti-apartheid campaigner, thespian and cannabis activist.
2
648
Henry Fisher retweeted
Recruitment announcement:- Come & join me on The Loop Board of Trustees! The Loop CIO is expanding its Board ahead of an exciting new phase of expansion of #harmreduction services coming very soon. If you know a suitable competent & committed accountant please RT to them. 🙏🏻
The Loop are currently recruiting for the role of Trustee (Treasurer)! Please follow this link for more information and to apply for this position with us. charityjob.co.uk/volunteer-j…
7
11
4,487
I’m excited about this - a frank, thoughtful, and participatory discussion of interdisciplinarity in psychedelic research with @NeseLSD and Emily Bloesch!
Join us on August 14th from 11:30am-1pm PST for "Silos to Synergy: How Collaboration Across Disciplines Changes the Research Landscape": Featuring @TehseenNoorani, @NeseLSD and Emily Bloesch. Learn more and apply here: lnkd.in/gUE846Gr
7
19
3,185
We are recruiting for a study on 'the many faces of psychedelic transformations': positive, negative and mixed significant changes. Please share to contribute to our understanding of the different outcomes that follow psychedelic experiences bit.ly/transformexe
2
12
19
5,278
National coverage today of new psilocybin cost-effectiveness report co-authored by Clerkenwell Health's Dr Henry Fisher and Clare Knight with Greenwich University and Drug Science.
2
7
3
32
3,374
Really interesting piece of research being conducted by @HDourron
This Post is from an account that no longer exists. Learn more
2
321
We are less than an hour away from our webinar with @clerkenwell_uk, register below to join the conversation! bit.ly/3WohnfJ #webinar #psychedelicswebinar #psychedelics #mentalhealth #clinicaltrials
2
6
479
Don’t miss out! Join our webinar tomorrow as speakers from PharmAla Biotech and @clerkenwell_uk discuss the work we’ve done together, optimizing trial design/clinical development and the current state of the market. bit.ly/3WohnfJ #psychedelics #webinar
4
1
18
1,356
Important parliamentary debate this morning led by the great @charlotte2153 and her cross-bench colleagues on their motion to improve access to psilocybin treatments: whatson.parliament.uk/
3
14
8,057